Skip to main content

BENEFICIOS Y RIESGOS DE LAS RESPUESTAS INMUNOLOGICAS A LA ISQUEMIA CEREBRAL

SAF2014-56279-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2014
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

CNS-border associated macrophages respond to acute ischemic stroke attracting granulocytes and promoting vascular leakage

  • Pedragosa, Jordi
  • Salas-Perdomo, Angélica
  • Gallizioli, Mattia
  • Cugota, Roger
  • Miró-Mur, Francesc
  • Briansó, Ferran
  • Justicia, Carles
  • Pérez-Asensio, Fernando J.
  • Márquez-Kisinousky, Leonardo
  • Urra, Xabier
  • Gieryng, Anna
  • Kaminska, Bozena
  • Chamorro, Ángel
  • Planas, Anna M.
The central nervous system (CNS) contains several types of immune cells located in specific anatomic compartments. Macrophages reside at the CNS borders surrounding the brain vessels, in leptomeningeal spaces and the choroid plexus, where they interact with the vasculature and play immunological surveillance and scavenging functions. We investigated the phenotypic changes and role of these macrophages in response to acute ischemic stroke. Given that CD163 expression is a hallmark of perivascular and meningeal macrophages in the rat and human brain, we isolated CD163+ brain macrophages by fluorescence activated cell sorting. We obtained CD163+ cells from control rats and 16 h following transient middle cerebral artery occlusion, after verifying that infiltration of CD163+ peripheral myeloid cells is negligible at this acute time point. Transcriptome analysis of the sorted CD163+ cells identified ischemia-induced upregulation of the hypoxia inducible factor-1 pathway and induction of genes encoding for extracellular matrix components and leukocyte chemoattractants, amongst others. Using a cell depletion strategy, we found that CNS border-associated macrophages participate in granulocyte recruitment, promote the expression of vascular endothelial growth factor (VEGF), increase the permeability of pial and cortical blood vessels, and contribute to neurological dysfunction in the acute phase of ischemia/reperfusion. We detected VEGF expression surrounding blood vessels and in some CD163+ perivascular macrophages in the brain tissue of ischemic stroke patients deceased one day after stroke onset. These findings show ischemia-induced reprogramming of the gene expression profile of CD163+ macrophages that has a rapid impact on leukocyte chemotaxis and blood-brain barrier integrity, and promotes neurological impairment in the acute phase of stroke., Supported by the Spanish Ministerio de Economia y Competitividad (SAF2014–56279-R and SAF2017–87459-R). JP and MG were supported by a PhD fellowship from the Catalan Research Agency (AGAUR) and the ITN program of the European Community (NeuroInflammation, FP7-PEOPLE-2013-ITN-n°607962), respectively. FMM is recipient of an ICT award by the Pla estratègic de recerca i innovació en salut (PERIS) of the Departament de Salut, Generalitat de Catalunya.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Structural and functional brain alterations in a murine model of Angiotensin II-induced hypertension

  • Meissner, Anja
  • Jens Minnerup
  • Soria, Guadalupe
  • Planas, Anna M.
Hypertension is a main risk factor for the development of cerebral small vessel disease (cSVD) – a major contributor to stroke and the most common cause of vascular dementia. Despite the increasing socioeconomic importance arising from cSVD, currently only a few specific treatment strategies with proven efficacy are known. Fundamental to the lack of specific treatments is poor understanding of the disease pathogenesis and a lack of appropriate animal models resembling all symptoms of the human disease. However, chronic hypertensive rat models have been shown to bear similarities to most key features of cSVD. Despite a significantly larger toolbox available for genotypic and phenotypic modifications compared to rats, mouse models of hypertension are unusual when modeling cSVD and associated cognitive impairment experimentally. In the present study, we therefore characterized hypertension‐mediated cerebrovascular alterations and accompanying structural and functional consequences by simultaneously treating adult wild‐type mice (C57BL/6N) with Angiotensin II (AngII) and the nitric oxide synthases inhibitor L‐NAME for 4 weeks. Hypertension associated to cerebral alterations reminiscent of early‐onset cSVD and vascular cognitive impairment when combined with additional AngII bolus injections. Most importantly, preventing the elevation of blood pressure (BP) protected from the development of cSVD symptoms and associated cognitive decline. Our data strongly support the suitability of this particular mouse model of AngII‐induced hypertension as an appropriate animal model for early‐onset cSVD and hence, vascular cognitive impairment, pathologies commonly preceding vascular dementia., We gratefullyacknowledge the following funding support research grant from theSpanish Ministry of Economy (MICINN SAF2014-56279), a MarieCurie Action of the 7th Framework Program of the EuropeanCommission (AM; 2013_229673), a stipend for returning scientistsgranted from the German Academic Exchange Service (AM;PKZ2015_91606607), and the Else Kr€oner Fresenius Stiftung (JM;2014_EKES.16)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Uric acid Is protective after cerebral ischemia/reperfusion in hyperglycemic mice

  • Justicia, Carles
  • Salas-Perdomo, Angélica
  • Pérez-de-Puig, Isabel
  • Deddens, Lisette H.
  • Tilborg, & Geralda A.F. van
  • Castellví, Clara
  • Dijkhuizen, Rick M.
  • Chamorro, Ángel
  • Planas, Anna M.
Hyperglycemia at stroke onset is associated with poor long-term clinical outcome in numerous studies. Hyperglycemia induces intracellular acidosis, lipid peroxidation, and peroxynitrite production resulting in the generation of oxidative and nitrosative stress in the ischemic tissue. Here, we studied the effects of acute hyperglycemia on in vivo intercellular adhesion molecule-1 (ICAM-1) expression, neutrophil recruitment, and brain damage after ischemia/reperfusion in mice and tested whether the natural antioxidant uric acid was protective. Hyperglycemia was induced by i.p. administration of dextrose 45 min before transient occlusion of the middle cerebral artery. Magnetic resonance imaging (MRI) was performed at 24 h to measure lesion volume. A group of normoglycemic and hyperglycemic mice received an i.v. injection of micron-sized particles of iron oxide (MPIOs), conjugated with either anti-ICAM-1 antibody or control IgG, followed by T2*w MRI. Neutrophil infiltration was studied by immunofluorescence and flow cytometry. A group of hyperglycemic mice received an i.v. infusion of uric acid (16 mg/kg) or the vehicle starting after 45 min of reperfusion. ICAM-1-targeted MPIOs induced significantly larger MRI contrast-enhancing effects in the ischemic brain of hyperglycemic mice, which also showed more infiltrating neutrophils and larger lesions than normoglycemic mice. Uric acid reduced infarct volume in hyperglycemic mice but it did not prevent vascular ICAM-1 upregulation and did not significantly reduce the number of neutrophils in the ischemic brain tissue. In conclusion, hyperglycemia enhances stroke-induced vascular ICAM-1 and neutrophil infiltration and exacerbates the brain lesion. Uric acid reduces the lesion size after ischemia/reperfusion in hyperglycemic mice., This work was supported by the Spanish Ministerio de Economia y Competitividad (SAF2014-56279R and DPI2015-64358-C2-2-R) and the Netherlands Organization for Scientific Research (NWO; VIDI 917.76.347)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

CD69 Plays a Beneficial Role in Ischemic Stroke by Dampening Endothelial Activation

  • Brait, Vanessa
  • Miró-Mur, Francesc
  • Pérez-de-Puig, Isabel
  • Notario, Laura
  • Hurtado Villarejo, Begoña
  • Pedragosa, Jordi
  • Gallizioli, Mattia
  • Jiménez-Altayó, Francesc
  • Arbaizar-Rovirosa, María
  • Otxoa de Amezaga, Amaia
  • Monteagudo, Juan
  • Ferrer-Ferrer, Maura
  • Rosa, Xavier de la
  • Bonfill-Teixidor, Ester
  • Salas-Perdomo, Angélica
  • Hernández-Vidal, Alba
  • García de Frutos, Pablo
  • Lauzurica, Pilar
  • Planas, Anna M.
RATIONALE: CD69 is an immunomodulatory molecule induced during lymphocyte activation. Following stroke, T-lymphocytes upregulate CD69 but its function is unknown. OBJECTIVE: We investigated whether CD69 was involved in brain damage following an ischemic stroke. METHODS AND RESULTS: We used adult male mice on the C57BL/6 or BALB/c backgrounds, including wild-type mice and CD69-/- mice, and CD69+/+ and CD69-/- lymphocyte-deficient Rag2-/- mice, and generated chimeric mice. We induced ischemia by transient or permanent middle cerebral artery occlusion. We measured infarct volume, assessed neurological function, and studied CD69 expression, as well as platelet function, fibrin(ogen) deposition, and VWF (von Willebrand factor) expression in brain vessels and VWF content and activity in plasma, and performed the tail-vein bleeding test and the carotid artery ferric chloride-induced thrombosis model. We also performed primary glial cell cultures and sorted brain CD45-CD11b-CD31+ endothelial cells for mRNA expression studies. We blocked VWF by intravenous administration of anti-VWF antibodies. CD69-/- mice showed larger infarct volumes and worse neurological deficits than the wild-type mice after ischemia. This worsening effect was not attributable to lymphocytes or other hematopoietic cells. CD69 deficiency lowered the time to thrombosis in the carotid artery despite platelet function not being affected. Ischemia upregulated Cd69 mRNA expression in brain endothelial cells. CD69-deficiency increased fibrin(ogen) accumulation in the ischemic tissue, and plasma VWF content and activity, and VWF expression in brain vessels. Blocking VWF reduced infarct volume and reverted the detrimental effect of CD69-/- deficiency. CONCLUSIONS: CD69 deficiency promotes a prothrombotic phenotype characterized by increased VWF and worse brain damage after ischemic stroke. The results suggest that CD69 acts as a downregulator of endothelial activation., The study was funded by the Spanish Ministerio de Economía y Competitividad (MINECO; grant SAF2014-56279-R and SAF2017-87459-R to A.M. Planas), Acción Estratégica de Salud (grants AES 1366/13 and AESI 1346/16 to P. Lauzurica), and Fundació la Marató de TV3 (grants 474-082230 and 20153031 to P. Garcia-de-Frutos). F. Miró-Mur had a PERIS award by the Health Department of the Generalitat de Catalunya. A. Otxoa-de-Amezaga has an FPI fellowship (MINECO).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Microglial cell loss after ischemic stroke favors brain neutrophil accumulation

  • Otxoa de Amezaga, Amaia
  • Miró-Mur, Francesc
  • Pedragosa, Jordi
  • Gallizioli, Mattia
  • Justicia, Carles
  • Gaja-Capdevila, Núria
  • Ruíz-Jaén, Francisca
  • Salas-Perdomo, Angélica
  • Bosch, Anna
  • Calvo, María
  • Márquez-Kisinousky, Leonardo
  • Denes, Adam
  • Gunzer, Matthias
  • Planas, Anna M.
Stroke attracts neutrophils to the injured brain tissue where they can damage the integrity of the blood–brain barrier and exacerbate the lesion. However, the mechanisms involved in neutrophil transmigration, location and accumulation in the ischemic brain are not fully elucidated. Neutrophils can reach the perivascular spaces of brain vessels after crossing the endothelial cell layer and endothelial basal lamina of post-capillary venules, or migrating from the leptomeninges following pial vessel extravasation and/or a suggested translocation from the skull bone marrow. Based on previous observations of microglia phagocytosing neutrophils recruited to the ischemic brain lesion, we hypothesized that microglial cells might control neutrophil accumulation in the injured brain. We studied a model of permanent occlusion of the middle cerebral artery in mice, including microglia- and neutrophil-reporter mice. Using various in vitro and in vivo strategies to impair microglial function or to eliminate microglia by targeting colony stimulating factor 1 receptor (CSF1R), this study demonstrates that microglial phagocytosis of neutrophils has fundamental consequences for the ischemic tissue. We found that reactive microglia engulf neutrophils at the periphery of the ischemic lesion, whereas local microglial cell loss and dystrophy occurring in the ischemic core are associated with the accumulation of neutrophils first in perivascular spaces and later in the parenchyma. Accordingly, microglia depletion by long-term treatment with a CSF1R inhibitor increased the numbers of neutrophils and enlarged the ischemic lesion. Hence, microglial phagocytic function sets a critical line of defense against the vascular and tissue damaging capacity of neutrophils in brain ischemia., Supported by grants of the Ministerio de Economía y Competitividad (MINECO) (SAF2014-56279-R and SAF2017-87459-R).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Dendritic Cells and Microglia Have Non-redundant Functions in the Inflamed Brain with Protective Effects of Type 1 cDCs

  • Gallizioli, Mattia
  • Miró-Mur, Francesc
  • Otxoa de Amezaga, Amaia
  • Cugota, Roger
  • Salas-Perdomo, Angélica
  • Justicia, Carles
  • Brait, Vanessa
  • Ruíz-Jaén, Francisca
  • Arbaizar-Rovirosa, María
  • Pedragosa, Jordi
  • Bonfill-Teixidor, Ester
  • Gelderblom, Mathias
  • Magnus, Tim
  • Cano, Eva
  • Fresno, Carlos del
  • Sancho, David
  • Planas, Anna M.
CD11c dendritic cells infiltrate the brain after ischemic injury and share some features with microglia. Gallizioli et al. show that dendritic cells exhibit a transcriptional profile different from microglia and excel in antigen presentation. Microglia attract different DC subsets via chemokines, especially cDC1 that exert beneficial functions in cerebral ischemia.Brain CD11c cells share features with microglia and dendritic cells (DCs). Sterile inflammation increases brain CD11c cells, but their phenotype, origin, and functions remain largely unknown. We report that, after cerebral ischemia, microglia attract DCs to the inflamed brain, and astroglia produce Flt3 ligand, supporting development and expansion of CD11c cells. CD11c cells in the inflamed brain are a complex population derived from proliferating microglia and infiltrating DCs, including a major subset of OX40L conventional cDC2, and also cDC1, plasmacytoid, and monocyte-derived DCs. Despite sharing certain morphological features and markers, CD11c microglia and DCs display differential expression of pattern recognition receptors and chemokine receptors. DCs excel CD11c and CD11c microglia in the capacity to present antigen through MHCI and MHCII. Of note, cDC1s protect from brain injury after ischemia. We thus reveal aspects of the dynamics and functions of brain DCs in the regulation of inflammation and immunity., This work was funded by Ministerio de Ciencia, Innovación y Universidades (MICINN) co-financed by Fondo Europeo de Desarrollo Regional (FEDER) ( SAF2017-87459-R ), the European Union (EU) ( H2020-ITN-2018-813294-ENTRAIN ), and Fundació Marató TV3 ( 201723 to A.M.P. and D.S.). Work in the D.S. laboratory is funded by Centro Nacional de Investigaciones Cardiovasculares (CNIC), the European Research Council (ERC-2016-Consolidator Grant 725091 ), the EU ( 635122-PROCROP H2020 ), and MICINN-FEDER ( SAF2016-79040-R ). The EU ( FP7-PEOPLE-2013-ITN-n°07962 ) supported M. Gallizioli. The PERIS program of Generalitat de Catalunya supported F.M.-M. A.O.-d.-A. had a fellowship from MICINN-FPI ( BES-2015-074419 ). C.d.F. is supported by the AECC Foundation ( INVES192DELF ). We thank Anaxomics, the genomics and informatics BioCore Units of Centre for Genomic Regulation, the Cytomics and Experimental 7T MRI platforms of IDIBAPS, and the Advanced Optical Microscopy Unit-CCiT of the University of Barcelona for technical support. We thank Dr. U. Perpiñá for microscopy assistance. Plexxikon Inc. provided PLX5622 under a materials transfer agreement. Part of this work was performed at Centre de Recerca Biomèdica Cellex. The Centres de Recerca de Catalunya (CERCA) Program of Generalitat de Catalunya supports IDIBAPS.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Tesis doctoral (DoctoralThesis)

Mechanisms involved in microglial phagocytic activity in brain ischemia

  • Ochoa de Amezafa Sainz de la Maza, Amaia
Tesis llevada a cabo para conseguir el grado de Doctor por la Universidad de Barcelona.--2020-05-22, Cerebral ischemia is one of the leading causes of morbidity and mortality worldwide. Ischemic stroke initiates an acute inflammatory response, which involves microglial activation and leukocyte infiltration. Microglial cells are the brain resident phagocytic cells of the myeloid lineage. Microglia precursors invade the brain tissue at embryonic stages and do not exchange with peripheral myeloid cells during adulthood under steady-state conditions. Therefore, microglial cells acquire a brain-derived specific phenotype distinguishable from that of macrophages resident in other organs. To remove dead cells, microglia carry out phagocytic functions which are enhanced following acute brain damage such as stroke, where necrotic, apoptotic and other forms of neuronal cell death occur inducing a condition of sterile inflammation. After stroke, neutrophils are attracted to the injured brain tissue where they can damage the integrity of the blood–brain barrier and exacerbate the lesion. However, the mechanisms involved in neutrophil transmigration, location and accumulation in the ischemic brain are not fully elucidated yet. In this thesis, we hypothesized that microglial phagocytic function may be relevant for the progression of the lesion after brain ischemia since these cells remove dead neurons and infiltrating peripheral cells, like neutrophils. However, the signals involved in the process of cell recognition are not known. The study of this function will shed light to new therapeutic targets based on modulating the phagocytosis process in the context of ischemic stroke. We have approached this thesis research by using different mouse models, including microglia- and neutrophil-reporter mice, human samples, and by using various in vitro and in vivo strategies to impair microglial function by targeting different receptors: Colony stimulating factor 1 receptor CSF1R, the purinergic receptor P2RY12, GAS-6 and the C-type lectin receptor DECTIN-1. Innovative techniques were set-up for this purpose such as co-cultures between adult microglia cells with neutrophils, multiposition time-lapse studies and 3D-imaging techniques. With all these tools, this thesis research demonstrates that microglial phagocytosis of neutrophils and apoptotic neurons has fundamental consequences for the ischemic tissue. We found that reactive microglia engulf neutrophils at the periphery of the ischemic lesion, whereas local microglial cell loss and dystrophy occurring in the ischemic core are associated with the accumulation of neutrophils: first in perivascular spaces and later in the parenchyma. We also found that P2RY12, CSF1R and GAS-6 are involved in the phagocytic process of neutrophils and that Dectin-1 receptor is crucial for the phagocytosis of apoptotic neural cells. Finally, we extended the results to the human brain samples from patients who died as a consequence of stroke and studied the potential relevance of these findings for humans, adding weight to the in vivo and in vitro results. We demonstrate that human microglial cells are very active phagocytosing neutrophils. These microglial cells have strong proliferative characteristics and also present increased expression of the studied receptors. In conclusion, this thesis contributes to a better understanding of the role of microglial cells after brain ischemia and their intrinsic phagocytic function, in view of helping in the development of immunotherapeutic tools to fight the inflammatory damage caused by stroke., This study was funded by: - The Spanish Ministerio de Economia y Competitividad (MINECO) through the SAF2014-56279-R “Beneficios y riesgos de las respuestas inmunológicas a la isquemia cerebral” and SAF2017-87459-R “Leucocitos y microglia en el ictus: papel en la neuroinflamación y la tromboinflamación”. - The Spanish Ministry of Science and Technology by means of a predoctoral FPI grant (BES-2015-074419).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Tesis doctoral (DoctoralThesis)

Els macròfags perivasculars i la infiltració leucocitària en la isquèmia cerebral

  • Pedragosa, Jordi
Tesis doctoral presentada para lograr el título de Doctor por la Universidad de Barcelona, Facultad de Medicina, Programa de Doctorado en Biomedicina, [EN] Cerebral ischemia occurs as a result of a sudden reduction of blood flow to a brain area due to occlusion of a cerebral artery. In this cerebrovascular disease, a series of time-coordinated events take place: an acute phase characterized by an accentuated inflammatory response, followed by a subacute and a chronic phase in which tissue resolution and repair processes develop. Different cells of the immune system are involved in these different phases, as well as cells of the nervous system. The main objective of this doctoral dissertation was to elucidate the mechanisms involved in leukocyte infiltration into the ischemic brain and its contribution to brain injury and neurological deficit. The first work shows the ability of neutrophils to accumulate in the leptomeninges and in Virchow-Robin spaces, where they activate, and to ultimately access the ischemic brain parenchyma without having to cross the blood brain barrier. The second work highlights how the depletion of perivascular macrophages by intracerebroventricular injection of liposomes carrying clodronate reduces neutrophil infiltration, attenuates disruption of the blood-brain barrier, and improves neurological function in the acute phase of cerebral ischemia. The third work identifies a beneficial and pro-reparative role of brain-infiltrating macrophages mediated by their proangiogenic activity that favours the emergence of new cerebral vessels in the chronic phase after ischemic stroke. This work also unveils the phenotypic heterogeneity of CCR2+ infiltrating monocytes and suggests that the proangiogenic macrophages are not bone marrow-derived. Overall, this thesis shows the active role of leukocytes in the progression of ischemic injury, the migration of neutrophils to the affected brain parenchyma, the role of resident macrophages in this process, the ability of perivascular macrophages to destabilize the blood-brain barrier in the acute phase of the ischemia, and, in the longer term, the proangiogenic and reparative role of infiltrating macrophages. The study suggests that some components of the ischemia-induced early inflammatory stage may be needed to trigger subsequent tissue repair processes., [CA] La isquèmia cerebral es produeix com a conseqüència de la reducció sobtada del flux sanguini en una zona del cervell a causa de l'oclusió d'una artèria cerebral. En aquesta patologia vascular cerebral es produeixen una sèrie d'esdeveniments coordinats en el temps que permeten diferenciar una primera fase aguda caracteritzada per una resposta inflamatòria accentuada seguida d'una fase subaguda i una fase crònica on es produeixen processos de resolució i reparació tissular. En les diferents fases es veuen involucrades diferents cèl·lules del sistema immunitari, així com també les pròpies cèl·lules del sistema nerviós. El principal objectiu d'aquesta tesi doctoral ha estat esbrinar els mecanismes implicats en la infiltració de leucòcits al cervell isquèmic i la seva contribució a la lesió cerebral i dèficit neurològic. El primer treball estudia la migració dels neutròfils al cervell isquèmic, les vies anatòmiques implicades i la seva infiltració en el parènquima cerebral afectat. Els resultats identifiquen, tant en models experimentals en ratolí com en mostres post-mortem de pacients amb ictus, una nova via d'entrada de leucòcits al cervell isquèmic a través de les leptomeninges i els espais de Virchow-Robin, on s'acumulen, s'activen, desenvolupen processos de degranulació i formació de NETs i finalment s'infiltren al parènquima cerebral. El treball mostra la capacitat dels neutròfils d'accedir al cervell a través de les leptomeninges sense necessitat de creuar la barrera hematoencefàlica intracerebral, la qual cosa pot tenir importància a l'hora de dissenyar estratègies per prevenir la infiltració d'aquestes cèl·lules al cervell. El segon treball posa de manifest que l'atracció de neutròfils als espais perivasculars després de la isquèmia està intervinguda, al menys en part, per l'activació dels macròfags perivasculars en resposta a la hipòxia. Aquesta resposta modifica el patró d'expressió gènica, generant quimiocines i VEGF, pel que contribueix al trencament de la barrera hematoencefàlica. La depleció dels macròfags perivasculars mitjançant injecció intracerebroventricular de liposomes amb clodronat redueix la infiltració de neutròfils, atenua la disrupció de la barrera hematoencefàlica i millora la funció neurològica en la fase aguda de la isquèmia cerebral. Finalment, el tercer treball identifica un paper beneficiós i pro-reparador dels macròfags infiltrants al cervell isquèmic mitjançat per la seva activitat proangiogènica que afavoreix l'aparició de nous vasos cerebrals en les fases cròniques que segueixen a una etapa proinflamatòria inicial i transitòria. Aquest estudi també mostra que la població de monòcits CCR2+ infiltrants al cervell isquèmic és fenotípicament heterogènia i suggereix que els macròfags amb potencial angiogènic no es troben en la medul·la òssia. Aquests resultats poden ser rellevants pel disseny de teràpies cel·lulars basades en cèl·lules mieloides. Globalment aquesta tesi mostra el paper actiu dels leucòcits en la progressió de la lesió isquèmica, la migració de neutròfils al parènquima afectat i el paper dels macròfags residents en aquest procés, la capacitat dels macròfags perivasculars de desestabilitzar la barrera hematoencefàlica en la fase aguda de la isquèmia, i, a més llarg termini, el paper proangiogènic i reparador dels macròfags infiltrants. L'estudi suggereix que alguns components de l'etapa inflamatòria inicial induïda per la isquèmia poden ser necessaris per a desencadenar processos posteriors de reparació tissular., Aquest treball s’ha realitzat al Departament d’Isquèmia Cerebral i Neurodegeneració de l’Institut d’Investigacions Biomèdiques de Barcelona (IIBB) del CSIC-IDIBAPS, dins dels projectes nacionals del Ministeri d’Economia i Competitivitat (MINECO) SAF2011-30492, SAF2014– 56279-R i SAF2017–87459-R i amb l’ajuda de l’AGAUR de la Generalitat de Catalunya 2017- SGR-645. S’ha rebut el suport econòmic de la beca FI-DGR per a la contractació de personal investigador novell FI-DGR de l’any 2015 al 2018.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension

  • Meissner, Anja
  • Miro, Francesc
  • Jiménez-Altayó, Francesc
  • Jurado, Andrés
  • Vila, Elisabet
  • Planas, Anna M.
Hypertension is a complex condition involving functional and structural alterations of the microvasculature and an activation of the immune system. T-lymphocytes play a crucial role during the development of hypertension in experimental models, yet the underlying mechanisms remain elusive. Lymphocyte egress from lymph nodes is controlled by sphingosine-1-phosphate (S1P), a natural lipid mediator regulating immune cell and vascular function in health and disease. We therefore investigated the involvement of S1P signalling in the pathogenesis of hypertension., This work was supported by the Spanish Ministry of Economy (MICINN SAF2014-56279) (A.M.P.), a Marie Curie Action of the 7th Framework Program of the European Commission (A.M.), the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) (A.M.) and a stipend for returning scientists granted from the German Academic Exchange Service (A.M.; PKZ2015_91606607)., Peer reviewed